Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles

Open Access

Case Report

IJMDC. 2021; 5(1): 413-415

Rare NRAS mutation causing Noonan syndrome type 6 in a Saudi patient: case report

Sara A. Alomar, Anfal Alsultan, Halah Raaed AlMuhaidib, Sarah Khalid Aldhahri, Dalal K. Bubshait.

Background: Noonan syndrome is an autosomal dominant syndrome that is characterized by specific features including congenital heart defect, namely pulmonary stenosis, thorax deformity, short stature, and skin manifestations. Moreover, the syndrome is characterized by dysmorphic facial features of low-set ears, hypertelorism, ptosis, and downward slanting palpebral fissures. Noonan syndrome is associated with RASopathies, a group of overlapping genotype-phenotype-related syndromes. Eleven genes have been found to be causing Noonan syndrome, including PTPN11, SOS1, CBL, BRAF, RAF1, SHOC2, MAP2K1, RIT1, NRAS, KRAS, and RRAS. It has been reported that NRAS mutation was detected in Noonan syndrome which is very limited and estimated to be only 2% of all Noonan syndrome cases.
Case Presentation: In this paper, we report a rare case of mutation of the NRAS gene causing Noonan syndrome type 6 in a 10-year-old Saudi child. The patient in his early infancy had early motor delay. Moreover, he had some of the characteristics of the disease, namely the dysmorphic features, including low-set ears, hypertelorism, short neck, downward slanting palpebral fissures, and wide-spaced nipples. He has left eye ptosis and refractory errors. In addition, the echocardiogram showed pulmonary stenosis.
Conclusion: Noonan syndrome is a clinically and genetically heterogenous autosomal dominant disorder. The classical clinical features used to diagnose it include short stature and congenital heart disease. However, it can affect all body systems. Thus, achieving an accurate diagnosis is crucial.

Key words: RASopathies, Noonan syndrome, NRAS, Autosomal dominant, Saudi Arabia

Similar Articles

Chemometric analysis of the global pattern of volatile organic compounds in the exhaled breath of patients with COVID-19, post-COVID and healthy subjects. Proof of concept for post-COVID assessment.
Zamora-Mendoza BN, Díaz de León-Martínez L, Rodríguez-Aguilar M, Mizaikoff B, Flores-Ramírez R
Talanta. 2022; 236(): 122832

Clinical Evaluation of the Rapid STANDARD Q COVID-19 Ag Test for the Screening of Severe Acute Respiratory Syndrome Coronavirus 2.
Kim HW, Park M, Lee JH
Annals of laboratory medicine. 2022; 42(1): 100-104

Prevalence of a Single-Nucleotide Variant of SARS-CoV-2 in Korea and Its Impact on the Diagnostic Sensitivity of the Xpert Xpress SARS-CoV-2 Assay.
Hong KH, In JW, Lee J, Kim SY, Lee KA, Kim S, An Y, Lee D, Sung H, Kim JS, Lee H
Annals of laboratory medicine. 2022; 42(1): 96-99

Clinical Utility of Methylation-Specific Multiplex Ligation-Dependent Probe Amplification for the Diagnosis of Prader-Willi Syndrome and Angelman Syndrome.
Kim B, Park Y, Cho SI, Kim MJ, Chae JH, Kim JY, Seong MW, Park SS
Annals of laboratory medicine. 2022; 42(1): 79-88

The Importance of Experimental Investigation of the CNS Oxytocin System.
Boulton KA, Guastella AJ
Methods in molecular biology (Clifton, N.J.). 2022; 2384(): 53-65

Full-text options

Latest Statistics about COVID-19
• pubstat.org

Add your Article(s) to Indexes
• citeindex.org

Covid-19 Trends and Statistics
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.

ScopeMed Web Sites